» Authors » Philippe Reinert

Philippe Reinert

Explore the profile of Philippe Reinert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 387
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bernaudin F, Verlhac S, Arnaud C, Kamdem A, Chevret S, Hau I, et al.
Blood . 2010 Nov; 117(4):1130-40. PMID: 21068435
Transcranial Doppler (TCD) is used to detect children with sickle cell anemia (SCA) who are at risk for stroke, and transfusion programs significantly reduce stroke risk in patients with abnormal...
2.
Reinert P, Cinquetti S, Soubeyrand B, Biasio L, Meghlaoui G, Thomas S, et al.
Adv Ther . 2010 Feb; 27(1):28-38. PMID: 20182924
Introduction: The World Health Organization (WHO) recommends universal infant hepatitis B virus (HBV) vaccination as the most effective preventive measure against HBV-induced disease in endemic areas. More than 160 countries...
3.
Pinquier D, Gagneur A, Balu L, Brissaud O, Gras Le Guen C, Hau-Rainsard I, et al.
Clin Vaccine Immunol . 2009 Jan; 16(4):484-7. PMID: 19176690
Varicella is a widespread disease of childhood resulting from primary infection with varicella-zoster virus (VZV). The objective of this study was to determine the kinetics of the decline of maternal...
4.
Gagneur A, Pinquier D, Aubert M, Balu L, Brissaud O, De Pontual L, et al.
Clin Vaccine Immunol . 2008 Sep; 15(12):1845-50. PMID: 18815232
The optimal age for measles vaccination is an important health issue, since maternal antibodies may neutralize the vaccine antigen before a specific immune response develops, while delaying vaccination may increase...
5.
Reinert P, Stagnara J, Roy P, Mallet E, Gaudelus J
Rev Prat . 2007 Dec; 57(16):1767-73. PMID: 18092719
Recurrent upper respiratory tract infections should be considered as a normal process in infants who build immune defenses in an environment where they meet viruses. Nasal lavage with saline serum...
6.
Reinert P, Benkerrou M, De Montalembert M, Lesprit E, Abadie I, Bernaudin F, et al.
Pediatr Infect Dis J . 2007 Nov; 26(12):1105-9. PMID: 18043446
Objectives: To evaluate safety and immunogenicity of the pneumococcal 7-valent conjugate vaccine (PCV7) when administered to infants with sickle cell disease (SCD) at 2, 3, and 4 months of age...
7.
Pinquier D, Gagneur A, Aubert M, Brissaud O, Gras Le Guen C, Hau-Rainsard I, et al.
Pediatr Infect Dis J . 2007 Sep; 26(8):749-50. PMID: 17848891
Measles antibody titers were measured in 210 French women. Ninety-four percent had protective values (>120 mIU/mL). Geometric mean titers were significantly different (P < 0.001) between women born before and...
8.
Sermet-Gaudelus I, Renouil M, Fajac A, Bidou L, Parbaille B, Pierrot S, et al.
BMC Med . 2007 Mar; 5:5. PMID: 17394637
Background: Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein, which acts as a chloride channel activated by cyclic AMP...
9.
Reinert P, Fiquet A, Thomas S, Schuyleman A, Watson M
Hum Vaccin . 2006 Oct; 2(5):215-21. PMID: 17035735
Objective: New multivalent vaccines simplify childhood immunisation schedules and can increase vaccination coverage. However, they must have a reactogenicity profile which is acceptable and comparable with that of previously available...
10.
Bingen E, Levy C, De La Rocque F, Boucherat M, Varon E, Alonso J, et al.
Clin Infect Dis . 2005 Sep; 41(7):1059-63. PMID: 16142676
From January 2001 through December 2003, a total of 1084 children with bacterial meningitis were enrolled in a prospective French nationwide survey. The most frequent pathogens found in children older...